EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Automated Microfluidic System for Haemostasis Assessment in Cirrhosis With Thrombocytopenia

Niccolò Bitto iD, Giulia Tosetti iD, Armando Tripodi iD, Anna Lecchi iD, Silvia La Marca, Lidia Padovan, Erica Scalambrino iD, Marigrazia Clerici iD, Camilla Caputo iD, Martina Lucà, Massimo Primignani, Anna Ludovica Fracanzani und 3 weitere

Liver International · 2026

DOI: 10.1111/liv.70871 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2026. Verfasst von Niccolò Bitto und 14 weiteren Autor:innen. Beteiligte Einrichtung: Foundation I.R.C.C.S. Ca' Granda, Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy. Hauptthemen laut MEDLINE: Thrombocytopenia, Liver Cirrhosis, Hemostasis, Thrombosis. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute-Bando Ricerca Corrente, European Union, Fourth EU Health Programme, Ministero dell'Università e della Ricerca ('Dipartimenti di Eccellenza' Programme 2023-27).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims Conventional laboratory tests do not capture platelet–vessel wall interactions (primary haemostasis) occurring in vivo, limiting guidance before invasive procedures. This is relevant in patients with thrombocytopenia, hallmark of advanced cirrhosis. Microfluidic assays may overcome these limitations. The Total Thrombus Analysis System (T‐TAS) is a flow chamber that can be adapted for thrombocytopenic samples when equipped with the HD‐CHIP. The CirTAS study aimed to assess T‐TAS reproducibility and the ability to identify a disease‐severity gradient in patients with cirrhosis and thrombocytopenia.

Methods

Eighty‐one patients with cirrhosis and thrombocytopenia were enrolled (20 Child–Pugh A, 41 B/C and 20 B/C with bacterial infection). T‐TAS measurements were performed using the HD‐CHIP. Reproducibility was assessed by intraclass correlation coefficients. Thromboelastometry (ROTEM) parameters were analysed in parallel. Multivariable and piecewise regression analyses were performed to test factors influencing T‐TAS parameters.

Results

T‐TAS showed high reproducibility, with intraclass correlation coefficients ≈0.90 for all parameters ( p < 0.001), even in platelet counts < 50 × 10 9 /L. Thrombus formation under flow declined with worsening clinical status and presence of bacterial infection ( p < 0.05). Alongside, ROTEM showed a trend towards hypocoagulability with increasing disease severity and correlated with T‐TAS parameters. Platelet count and factor VIII (FVIII) were independent determinants of the most representative T‐TAS parameters. Exploratory analyses detected a trend towards a stronger platelet count‐T‐TAS association at 30–50 × 10 9 /L.

Conclusions

T‐TAS is reproducible in thrombocytopenic cirrhosis and is associated with reduced thrombus formation alongside disease progression and bacterial infection. Platelet count and FVIII are the main determinants of thrombus formation assessed by T‐TAS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombocytopeniaLiver CirrhosisHemostasisThrombosisMicrofluidicsHumansFemaleMaleReproducibility of ResultsMiddle AgedAgedSeverity of Illness IndexPlatelet CountAdult

Stichwörter der Autor:innen

FVIIIcirrhosiscoagulopathyflow chamberplatelets

Autor:innen und Institutionen

  • Foundation I.R.C.C.S. Ca' Granda, Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy.
  • Foundation I.R.C.C.S. Ca' Granda, Ospedale Maggiore Policlinico, Gastroenterology and Hepatology Division, Milan, Italy.
  • Foundation Luigi Villa, Milan, Italy.
  • Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
  • Foundation I.R.C.C.S. Ca' Granda, Ospedale Maggiore Policlinico, Unit of Internal Medicine and Metabolic Diseases, Milan, Italy.
  • CRC "A. M. and A. Migliavacca" Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

ORCID-Profile: Niccolò Bitto, Giulia Tosetti, Armando Tripodi, Anna Lecchi, Erica Scalambrino, Marigrazia Clerici, Camilla Caputo, Pietro Lampertico, Flora Peyvandi, Vincenzo La Mura

Förderung

  • Ministero della Salute-Bando Ricerca Corrente
  • European Union, Fourth EU Health Programme
  • Ministero dell'Università e della Ricerca ('Dipartimenti di Eccellenza' Programme 2023-27)
  • European Commission

Zitieren

APA

Bitto, N., Tosetti, G., Tripodi, A., Lecchi, A., La Marca, S., Padovan, L., Scalambrino, E., Clerici, M., Caputo, C., Lucà, M., Primignani, M., Fracanzani, A. L., Lampertico, P., Peyvandi, F., & La Mura, V. (2026). An Automated Microfluidic System for Haemostasis Assessment in Cirrhosis With Thrombocytopenia. Liver International. https://doi.org/10.1111/liv.70871

Vancouver

Bitto N, Tosetti G, Tripodi A, Lecchi A, La Marca S, Padovan L, et al. An Automated Microfluidic System for Haemostasis Assessment in Cirrhosis With Thrombocytopenia. Liver International. 2026. doi:10.1111/liv.70871

BibTeX
@article{Bitto2026,
  author = {Bitto, Niccolò and Tosetti, Giulia and Tripodi, Armando and Lecchi, Anna and La Marca, Silvia and Padovan, Lidia and Scalambrino, Erica and Clerici, Marigrazia and Caputo, Camilla and Lucà, Martina and Primignani, Massimo and Fracanzani, Anna Ludovica and Lampertico, Pietro and Peyvandi, Flora and La Mura, Vincenzo},
  title = {An Automated Microfluidic System for Haemostasis Assessment in Cirrhosis With Thrombocytopenia},
  journal = {Liver International},
  year = {2026},
  doi = {10.1111/liv.70871}
}
Kostenlos starten →